{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T05:42:03Z","timestamp":1772257323614,"version":"3.50.1"},"reference-count":24,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T00:00:00Z","timestamp":1583971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicines"],"abstract":"<jats:p>Background: Serum phosphate levels, which are associated with the progression of renal dysfunction in chronic kidney disease, in patients with autosomal dominant polycystic kidney disease (ADPKD) are lower than those in patients with other kidney diseases. However, their role in ADPKD remains unclear. This study aimed to determine whether serum phosphate levels could have an association with renal prognoses among patients with ADPKD. Methods: In total, 55 patients with PKD1 or PKD2 mutations but not undergoing dialysis were evaluated. Data regarding serum phosphate levels were collected, and Cox regression analyses were used to calculate hazard ratios (HRs) with renal replacement therapy as the endpoint. Results: The median (quartile 1; quartile 3) serum phosphate concentration was 3.4 (3.1; 3.9) mg\/dL, and the estimated glomerular filtration rate (eGFR) was 39.5 (17.6; 65.7) mL\/min\/1.73 m2. The multivariate analysis that included age, PKD1 mutation, eGFR, urinary protein excretion, hyperuricemia, and serum phosphate determined that eGFR (HR, 0.82; 95% confidence interval (CI), 0.74\u20130.90; p &lt; 0.0001) and serum phosphate (HR, 6.78; 95% CI, 1.94\u201334.02; p = 0.0021) were independently associated with renal replacement therapy. Conclusions: We found that serum phosphate levels were significantly associated with poor renal prognoses in patients with ADPKD.<\/jats:p>","DOI":"10.3390\/medicines7030013","type":"journal-article","created":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T12:22:51Z","timestamp":1584015771000},"page":"13","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["High Serum Phosphate Level as a Risk Factor to Determine Renal Prognosis in Autosomal Dominant Polycystic Kidney Disease: A Retrospective Study"],"prefix":"10.3390","volume":"7","author":[{"given":"Masayo","family":"Sato","sequence":"first","affiliation":[{"name":"Department of Nephrology, Tokyo Women\u2019s Medical University, Tokyo 162-8666, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9543-7608","authenticated-orcid":false,"given":"Hiroshi","family":"Kataoka","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Tokyo Women\u2019s Medical University, Tokyo 162-8666, Japan"},{"name":"Clinical Research Division for Polycystic Kidney Disease, Department of Nephrology, Tokyo Women\u2019s Medical University, Tokyo 162-8666, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Ushio","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Tokyo Women\u2019s Medical University, Tokyo 162-8666, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun","family":"Manabe","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Tokyo Women\u2019s Medical University, Tokyo 162-8666, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saki","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Tokyo Women\u2019s Medical University, Tokyo 162-8666, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taro","family":"Akihisa","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Tokyo Women\u2019s Medical University, Tokyo 162-8666, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiho","family":"Makabe","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Tokyo Women\u2019s Medical University, Tokyo 162-8666, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rie","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Tokyo Women\u2019s Medical University, Tokyo 162-8666, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi","family":"Iwasa","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Tokyo Women\u2019s Medical University, Tokyo 162-8666, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michihiro","family":"Mitobe","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Tokyo Women\u2019s Medical University, Tokyo 162-8666, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Hanafusa","sequence":"additional","affiliation":[{"name":"Department of Blood Purification, Kidney Center, Tokyo Women\u2019s Medical University, Tokyo 162-8666, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Tsuchiya","sequence":"additional","affiliation":[{"name":"Department of Blood Purification, Kidney Center, Tokyo Women\u2019s Medical University, Tokyo 162-8666, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosaku","family":"Nitta","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Tokyo Women\u2019s Medical University, Tokyo 162-8666, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3820-3191","authenticated-orcid":false,"given":"Toshio","family":"Mochizuki","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Tokyo Women\u2019s Medical University, Tokyo 162-8666, Japan"},{"name":"Clinical Research Division for Polycystic Kidney Disease, Department of Nephrology, Tokyo Women\u2019s Medical University, Tokyo 162-8666, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,3,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10157-012-0741-0","article-title":"Autosomal dominant polycystic kidney disease: Recent advances in pathogenesis and potential therapies","volume":"17","author":"Mochizuki","year":"2013","journal-title":"Clin. Exp. Nephrol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1681\/ASN.V8101560","article-title":"Identification of patients with autosomal dominant polycystic kidney disease at highest risk for end-stage renal disease","volume":"8","author":"Johnson","year":"1997","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1681\/ASN.2015010016","article-title":"The PROPKD Score: A New Algorithm to Predict Renal Survival in Autosomal Dominant Polycystic Kidney Disease","volume":"27","author":"Audrezet","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Kataoka, H., Fukuoka, H., Makabe, S., Yoshida, R., Teraoka, A., Ushio, Y., Akihisa, T., Manabe, S., Sato, M., and Mitobe, M. (2020). Prediction of Renal Prognosis in Patients with Autosomal Dominant Polycystic Kidney Disease Using PKD1\/PKD2 Mutations. J. Clin. Med., 9.","DOI":"10.3390\/jcm9010146"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"640","DOI":"10.2215\/CJN.03250410","article-title":"Potentially modifiable factors affecting the progression of autosomal dominant polycystic kidney disease","volume":"6","author":"Torres","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Ushio, Y., Kataoka, H., Sato, M., Manabe, S., Watanabe, S., Akihisa, T., Makabe, S., Yoshida, R., Tsuchiya, K., and Nitta, K. (2020). Association between anemia and renal prognosis in autosomal dominant polycystic kidney disease: A retrospective study. Clin. Exp. Nephrol.","DOI":"10.1007\/s10157-020-01856-1"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2215\/CJN.02101205","article-title":"Association of disorders in mineral metabolism with progression of chronic kidney disease","volume":"1","author":"Schwarz","year":"2006","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/ki.2010.375","article-title":"Patients with autosomal dominant polycystic kidney disease have elevated fibroblast growth factor 23 levels and a renal leak of phosphate","volume":"79","author":"Pavik","year":"2011","journal-title":"Kidney Int."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1681\/ASN.2008050507","article-title":"Unified criteria for ultrasonographic diagnosis of ADPKD","volume":"20","author":"Pei","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1681\/ASN.2007010125","article-title":"Genotype-phenotype correlations in autosomal dominant and autosomal recessive polycystic kidney disease","volume":"18","author":"Rossetti","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1093\/ndt\/gfm286","article-title":"High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients","volume":"22","author":"Voormolen","year":"2007","journal-title":"Nephrol. Dial. Transpl."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1093\/ndt\/gfq808","article-title":"Serum phosphorus predicts incident chronic kidney disease and end-stage renal disease","volume":"26","author":"Hwang","year":"2011","journal-title":"Nephrol. Dial. Transpl."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1681\/ASN.2011020175","article-title":"Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition","volume":"22","author":"Zoccali","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Chang, W.X., Xu, N., Kumagai, T., Shiraishi, T., Kikuyama, T., Omizo, H., Sakai, K., Arai, S., Tamura, Y., and Ota, T. (2016). The Impact of Normal Range of Serum Phosphorus on the Incidence of End-Stage Renal Disease by A Propensity Score Analysis. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0154469"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1096\/fj.10-154765","article-title":"Klotho: A novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule","volume":"24","author":"Hu","year":"2010","journal-title":"FASEB J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/ki.2012.176","article-title":"Update on fibroblast growth factor 23 in chronic kidney disease","volume":"82","author":"Wolf","year":"2012","journal-title":"Kidney international."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"810","DOI":"10.2215\/CJN.08680811","article-title":"Combined use of vitamin D status and FGF23 for risk stratification of renal outcome","volume":"7","author":"Nakano","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/ndt\/gfs460","article-title":"Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: A sequence suggested from a cross-sectional study","volume":"28","author":"Pavik","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"248","DOI":"10.2215\/CJN.09020911","article-title":"Soluble klotho and autosomal dominant polycystic kidney disease","volume":"7","author":"Pavik","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/nep.12862","article-title":"Fibroblast growth factor 23 and soluble Klotho in patients with autosomal dominant polycystic kidney disease","volume":"22","author":"Akiyama","year":"2017","journal-title":"Nephrology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/ki.2013.526","article-title":"Renal expression of FGF23 and peripheral resistance to elevated FGF23 in rodent models of polycystic kidney disease","volume":"85","author":"Spichtig","year":"2014","journal-title":"Kidney Int."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1096\/fj.08-114397","article-title":"In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23) -mediated regulation of systemic phosphate homeostasis","volume":"23","author":"Nakatani","year":"2009","journal-title":"FASEB J."}],"container-title":["Medicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2305-6320\/7\/3\/13\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:06:13Z","timestamp":1760173573000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2305-6320\/7\/3\/13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,12]]},"references-count":24,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3]]}},"alternative-id":["medicines7030013"],"URL":"https:\/\/doi.org\/10.3390\/medicines7030013","relation":{},"ISSN":["2305-6320"],"issn-type":[{"value":"2305-6320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,12]]}}}